biotech

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

Earnings season is now in full swing, and we have put together a preview of some of the world’s largest biotechnology and pharmaceutical companies reporting their earnings on Thursday. With ...
Read Full Story »

Short Sellers Grow More Selective on Major Biotechs

The short interest data are out for the most recent settlement date, April 13. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

XBiotech Stock Crumbles Following Disappointing EMA Meeting

XBiotech Inc. (NASDAQ: XBIT) saw its shares fall sharply after the company issued an update on its recent meeting with the European Medical Agency (EMA). The Oral Explanation meeting dealt ...
Read Full Story »

Edge Therapeutics Rises Following Registered Direct Offering Announcement

Shares of Edge Therapeutics Inc. (NASDAQ: EDGE) posted a solid gain in Wednesday’s trading session after the company announced that it would be conducting a registered direct offering of its common ...
Read Full Story »

Audentes Therapeutics Gears Up for Secondary Offering

Audentes Therapeutics Inc. (NASDAQ: BOLD) saw its shares drop early on Wednesday after the company announced the pricing of its secondary offering. The company said that it intends to price ...
Read Full Story »

Why One Analyst Is Growing Very Bullish on Life Sciences

Over the past five, 10 and 20 years, the life sciences and bioproduction segments have tended to outperform the S&P 500 more often than not. Considering the exposure to biopharma ...
Read Full Story »

FDA Delivers Big Rheumatoid Athritis Disappointment for Eli Lilly and Incyte

Big Pharma and Big Biotech sometimes live and die by actions out of the U.S. Food and Drug Administration (FDA). For Eli Lilly and Co. (NYSE: LLY) and Incyte Corp. (NASDAQ: ...
Read Full Story »

Sorrento Therapeutics Gears Up for Secondary Offering

Sorrento Therapeutics Inc. (NASDAQ: SRNE) saw its shares plunge on Thursday after the company announced a secondary offering. The company has yet to disclose how many shares it plans to offer. ...
Read Full Story »

Neurocrine Biosciences Wins Big With FDA Approval

Neurocrine Biosciences Inc. (NASDAQ: NBIX) saw its shares jump after the company reported a key U.S. Food and Drug Administration (FDA) approval. Specifically, the agency approved Ingrezza (valbenazine) capsules for ...
Read Full Story »

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, March 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Why Jefferies Still Sees Exponential Upside in TherapeuticsMD

TherapeuticsMD Inc. (NYSEMKT: TXMD) saw its shares drop off earlier this month after the company received a letter from the U.S. Food and Drug Administration (FDA) citing deficiencies in its ...
Read Full Story »

Cytori Rises on Crucial FDA Approval

Cytori Therapeutics Inc. (NASDAQ: CYTX) saw its shares explode after it was reported that the firm received approval from the U.S. Food and Drug Administration (FDA) for its treatment of ...
Read Full Story »

Jefferies Thinks 3 Red-Hot Biotech Stocks Can Beat Q1 Estimates

If any industry has been under pressure over the past year or so, it has been biotechnology. While there are some positives for the industry, it still faces some definite ...
Read Full Story »

Why the First Marijuana ETF May Pose Serious Problems for US Investors

With the explosive growth in medical and recreational marijuana in America, a slew of emerging companies have come public and brought new interest by investors in recent years. With there ...
Read Full Story »

Catalyst Biosciences Sinks After Pricing Secondary Offering

Catalyst Biosciences Inc. (NASDAQ: CBIO) watched its shares fall on Friday following the announcement of a secondary offering. The company is focused on treatments in the field of hematology and ...
Read Full Story »